The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease ...

Aaron Holley, MD, writes that it takes a 'physiologic village' to create activity intolerance after pulmonary embolism, and argues for more use of cardiopulmonary exercise testing to evaluate it.

Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies.

Imbalances in oral microbiota and poor oral health are associated with increased migraines and body pain in women with central sensitization disorders, a new study shows.

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain following bariatric surgery, a Swiss real-world study reveals.

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred.

Severe postpartum haemorrhage in women with grade 3 placenta accreta spectrum demonstrates significantly better outcomes in Italy than in the United Kingdom and France.

Supervised lifestyle intervention from a medical professional may help maximize fat loss and minimize muscle tissue loss in people taking the potent weight loss drugs.

A retrospective study revealed that the link between early-life acid-suppressive therapy use and celiac disease autoimmunity may be confounded by healthcare utilization behavior.